ArticleMolecular cancer research : MCR2018

Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma.

Xinwei Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.